Corinne A. Betts
South Parks Road
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 06, 2024
Dystrophin involvement in peripheral circadian SRF signalling.
Journal: Life science alliance
Published: January 07, 2021
Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency.
Journal: Molecular therapy. Nucleic acids
Published: September 13, 2020
Functional Rescue of Dystrophin-Deficient mdx Mice by a Chimeric Peptide-PMO.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 05, 2020
Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 21, 2019
Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment.
Journal: Nucleic acid therapeutics
Published: October 12, 2018
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.
Journal: Human molecular genetics
Published: July 26, 2018
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Journal: Human molecular genetics
Published: June 26, 2018
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.
Journal: EBioMedicine
Published: March 03, 2018
Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
Journal: PloS one
Published: January 31, 2018
Corrigendum: Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.
Journal: Scientific reports
Published: December 20, 2016
Last Updated: 09/26/2026